A provider should help match the delivery method with your symptoms, goals, and health history
if youre a Pandia Health patient, message us anytime through our secure HIPAA compliant website
Semaglutide is typically administered as a once-weekly injection and has been shown to be effective in improving blood sugar control, promoting weight loss, and reducing cardiovascular risks in people with type 2 diabetes
This approval was based on results from the Semaglutide Treatment Effect in People with Obesity program (STEP) clinical trials, which evaluated the safety and efficacy of semaglutide as an aid for losing weight in individuals without diabetes
Patient confidentiality was maintained through the de-identification of data, and all records were stored securely with restricted access
But Healey urged commissioners to seriously consider the recommendation to scrap coverage for GLP-1 drugs for weight loss